82 related articles for article (PubMed ID: 1707245)
21. Prejunctional inhibitory effects of prostanoids on sympathetic neurotransmission in the rabbit iris-ciliary body.
Ohia SE; Jumblatt JE
J Pharmacol Exp Ther; 1990 Oct; 255(1):11-6. PubMed ID: 2170622
[TBL] [Abstract][Full Text] [Related]
22. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
[TBL] [Abstract][Full Text] [Related]
23. Cerebrovascular effects of prostanoids: in-vitro studies in feline middle cerebral and basilar artery.
Whalley ET; Schilling L; Wahl M
Prostaglandins; 1989 Dec; 38(6):625-34. PubMed ID: 2483755
[TBL] [Abstract][Full Text] [Related]
24. Atrial natriuretic factor inhibits adrenergic and purinergic neurotransmission in the rabbit isolated vas deferens.
Drewett JG; Trachte GJ; Marchand GR
J Pharmacol Exp Ther; 1989 Jan; 248(1):135-42. PubMed ID: 2536425
[TBL] [Abstract][Full Text] [Related]
25. Neural and myogenic effects of cyclooxygenase products on canine bronchial smooth muscle.
Abela AP; Daniel EE
Am J Physiol; 1995 Jan; 268(1 Pt 1):L47-55. PubMed ID: 7840228
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin peptides and prostaglandin E2 synthesis: modulation of neurogenic responses in the rabbit vas deferens.
Saye J; Binder SB; Trachte GJ; Peach MJ
Endocrinology; 1986 Nov; 119(5):1895-903. PubMed ID: 3464412
[TBL] [Abstract][Full Text] [Related]
27. The strong contractile effect of the thromboxane receptor agonist U-46619 in isolated human pulmonary arteries and its competitive antagonism by BM-13.505.
Sjöberg T; Steen S
Acta Physiol Scand; 1989 Jun; 136(2):161-5. PubMed ID: 2528885
[TBL] [Abstract][Full Text] [Related]
28. Role of Ca(2+)-activated K(+) channels and Na(+),K(+)-ATPase in prostaglandin E(1)- and E(2)-induced inhibition of the adrenergic response in human vas deferens.
Medina P; Segarra G; Mauricio MD; Vila JM; Chuan P; Lluch S
Biochem Pharmacol; 2011 Jul; 82(1):65-71. PubMed ID: 21458424
[TBL] [Abstract][Full Text] [Related]
29. Modulation of adrenergic responses by prostanoids in the isolated mesenteric vascular bed of the rat.
Mantelli L; Amerini S; Filippi S; Ledda F
Gen Pharmacol; 1993 Jul; 24(4):911-9. PubMed ID: 7693541
[TBL] [Abstract][Full Text] [Related]
30. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils.
Teixeira MM; al-Rashed S; Rossi AG; Hellewell PG
Br J Pharmacol; 1997 May; 121(1):77-82. PubMed ID: 9146890
[TBL] [Abstract][Full Text] [Related]
32. Effects of the thromboxane-receptor antagonists AH 23848 and BM 13.177 on human uteroplacental arteries.
Svane D; Skajaa K; Andersson KE; Forman A
Obstet Gynecol; 1992 Aug; 80(2):234-40. PubMed ID: 1386150
[TBL] [Abstract][Full Text] [Related]
33. Thromboxane receptors can modulate gastric acid secretion in the rat.
Reeves JJ; Stables R
Prostaglandins; 1987 Dec; 34(6):829-40. PubMed ID: 2966969
[TBL] [Abstract][Full Text] [Related]
34. Endogenous prostaglandin formation in the field-stimulated guinea-pig vas deferens: comparison of the inhibitory effects of indomethacin and NS-398.
Miller MR; Johnson FC; Poyser NL
Prostaglandins Leukot Essent Fatty Acids; 1999 Dec; 61(6):363-8. PubMed ID: 10718109
[TBL] [Abstract][Full Text] [Related]
35. Atrial natriuretic peptide inhibits the purinergic and not the adrenergic component of electrically induced contractile responses in guinea pig vas deferens.
Mutafova-Yambolieva VN; Venkova KM; Lasova LS
J Pharmacol Exp Ther; 1993 May; 265(2):920-6. PubMed ID: 8098767
[TBL] [Abstract][Full Text] [Related]
36. Effects of the new thromboxane A2 antagonist vapiprost on isolated canine blood vessels.
Matsuzaki T; Noguchi K; Nakasone J; Uezu K; Higuchi M; Sakanashi M
Arzneimittelforschung; 1992 Nov; 42(11):1318-22. PubMed ID: 1492844
[TBL] [Abstract][Full Text] [Related]
37. Investigation of postjunctional alpha1- and alpha2-adrenoceptor subtypes in vas deferens from wild-type and alpha(2A/D)-adrenoceptor knockout mice.
Cleary L; Vandeputte C; Docherty JR
Br J Pharmacol; 2003 Mar; 138(6):1069-76. PubMed ID: 12684262
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of cyclo-oxygenase pathway metabolites on cytokine production by T lymphocytes.
Della Bella S; Molteni M; Compasso S; Zulian C; Vanoli M; Scorza R
Prostaglandins Leukot Essent Fatty Acids; 1997 Mar; 56(3):177-84. PubMed ID: 9089795
[TBL] [Abstract][Full Text] [Related]
39. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
Walch L; de Montpreville V; Brink C; Norel X
Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
[TBL] [Abstract][Full Text] [Related]
40. Effects of prostanoids and indomethacin on isolated smooth muscle from the human lower oesophagus.
Tøttrup A; Forman A; Raundahl U; Andersson KE
Pharmacol Toxicol; 1992 Jul; 71(1):65-74. PubMed ID: 1523197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
